Metastatic Colorectal Cancers Completed Phase 1 Trials for Plerixafor (DB06809)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02179970To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal CancersTreatment